Ignite Creation Date:
2024-05-05 @ 4:54 PM
Last Modification Date:
2024-10-26 @ 9:26 AM
Study NCT ID:
NCT00347789
Status:
COMPLETED
Last Update Posted:
2006-07-04
First Post:
2006-06-30
Brief Title:
Effectiveness of a Procedure for Previously Failed Glaucoma Surgery
Sponsor:
Glaucoma Research Education Group
Organization:
Glaucoma Research Education Group
Study Overview
Official Title:
Efficacy of Transconjunctival Mitomycin-C in Needle Revisions of Failing Trabeculectomy
Status:
COMPLETED
Status Verified Date:
2006-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Transconjunctival mitomycin-C in needle bleb revision may be an effective procedure to treat cases with a previously failed trabeculectomy We will investigate approximately 100 consecutive cases with follow up of up to 9 years We anticipate that this procedure is an effective safe and appropriate option for successful glaucoma treatment
Detailed Description:
The healing process after filtering surgery for glaucoma may cause an unsuccessful outcome for the trabeculectomy procedure In order to control the rising intraocular pressure due to the failed trabeculectomy medications may be restarted andor filtering surgery may need to be repeated Our primary research showed that transconjunctival mitomycin-C in needle bleb revision may be an effective procedure to control this situation
This retrospective study will follow over 100 patients from May 1997 to May 2006 This long-term follow up will help assess the future role of this technique in glaucoma practices
This retrospective study will follow over 100 patients from May 1997 to May 2006 This long-term follow up will help assess the future role of this technique in glaucoma practices
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None